Publication List 2012

1984-94, 1995, 1996, 1997, 1998, 1999, 2000, 2001, 2002, 2003, 2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011, 2012, 2013, 2014, 2015, 2016, 2017, 2018, 2019, 2020, 2021, 2022

16
（395）		 Miyazono K.
Tumour promoting functions of TGF-β in CML-initiating cells.
J Biochem. 2012 Nov;152(5):383-5.
15
（394）		 Takaesu NT, Stinchfield MJ, Shimizu K, Arase M, Quijano JC, Watabe T, Miyazono K, Newfeld SJ.
Drosophila CORL is required for Smad2-mediated activation of Ecdysone Receptor expression in the mushroom body.
Development. 2012 Sep;139(18):3392-401.
14
（393）		 Harada M, Iwata C, Saito H, Ishii K, Hayashi T, Yashiro M, Hirakawa K, Miyazono K, Kato Y, Kano MR.
NC-6301, a polymeric micelle rationally optimized for effective release of docetaxel, is potent but is less toxic than native docetaxel in vivo.
Int J Nanomedicine. 2012;7:2713-27.
13
（392）		 Nishimori H, Ehata S, Suzuki HI, Katsuno Y, Miyazono K.
Prostate cancer cells and bone stromal cells mutually interact with each other through bone morphogenetic protein-mediated signals.
J Biol Chem. 2012 Jun 8;287(24):20037-46.
12
（391）		 Ishii R, Isogaya K, Seto A, Koinuma D, Watanabe Y, Arisaka F, Yaguchi S, Ikushima H, Dohmae N, Miyazono K, Miyazawa K, Ishitani R, Nureki O.
Structure of a dominant-negative helix-loop-helix transcriptional regulator suggests mechanisms of autoinhibition.
EMBO J. 2012 May 30;31(11):2541-52.
11
（390）		 Katsuno Y, Ehata S, Yashiro M, Yanagihara K, Hirakawa K, Miyazono K.
Coordinated expression of REG4 and aldehyde dehydrogenase 1 regulating tumourigenic capacity of diffuse-type gastric carcinoma-initiating cells is inhibited by TGF-β.
J Pathol. 2012 Nov;228(3):391-404.
10
（389）		 Tojo M, Takebe A, Takahashi S, Tanaka K, Imamura T, Miyazono K, Chiba T.
Smad7-deficient mice show growth retardation with reduced viability.
J Biochem. 2012 Jun;151(6):621-31.
9
（388）		 Rafi M, Cabral H, Kano MR, Mi P, Iwata C, Yashiro M, Hirakawa K, Miyazono K, Nishiyama N, Kataoka K.
Polymeric micelles incorporating (1,2-diaminocyclohexane)platinum (II) suppress the growth of orthotopic scirrhous gastric tumors and their lymph node metastasis.
J Control Release. 2012 Apr 30;159(2):189-96.
8
（387）		 Hosoya H, Kadowaki K, Matsusaki M, Cabral H, Nishihara H, Ijichi H, Koike K, Kataoka K, Miyazono K, Akashi M, Kano MR.
Engineering fibrotic tissue in pancreatic cancer: a novel three-dimensional model to investigate nanoparticle delivery.
Biochem Biophys Res Commun. 2012 Mar 2;419(1):32-7.
7
（386）		 Krieglstein K, Miyazono K, ten Dijke P, Unsicker K.
TGF-β in aging and disease.
Cell Tissue Res. 2012 Jan;347(1):5-9.
6
（385）		 Kawata M, Koinuma D, Ogami T, Umezawa K, Iwata C, Watabe T, Miyazono K.
TGF-β-induced epithelial-mesenchymal transition of A549 lung adenocarcinoma cells is enhanced by pro-inflammatory cytokines derived from RAW 264.7 macrophage cells.
J Biochem. 2012 Feb;151(2):205-16.
5
（384）		 Miyazono K, Ehata S, Koinuma D.
Tumor-promoting functions of transforming growth factor-β in progression of cancer.
Ups J Med Sci. 2012 May;117(2):143-52.
4
（383）		 Horiguchi K, Sakamoto K, Koinuma D, Semba K, Inoue A, Inoue S, Fujii H, Yamaguchi A, Miyazawa K, Miyazono K, Saitoh M.
TGF-β drives epithelial-mesenchymal transition through δEF1-mediated downregulation of ESRP.
Oncogene. 2012 Jun 28;31(26):3190-201.
3
（382）		 Mihira H, Suzuki HI, Akatsu Y, Yoshimatsu Y, Igarashi T, Miyazono K, Watabe T.
TGF-β-induced mesenchymal transition of MS-1 endothelial cells requires Smad-dependent cooperative activation of Rho signals and MRTF-A.
J Biochem. 2012 Feb;151(2):145-56.
2
（381）		 Miyazono K.
Ectodomain shedding of HB-EGF: a potential target for cancer therapy.
J Biochem. 2012 Jan;151(1):1-3.
1
（380）		 Ikushima H, Miyazono K.
TGF-β signal transduction spreading to a wider field: a broad variety of mechanisms for context-dependent effects of TGF-β.
Cell Tissue Res. 2012 Jan;347(1):37-49.